Braveheart Bio, Inc. (BRVE) vs Alpha Tau Medical Ltd (DRTS)

A side-by-side comparison of Braveheart Bio, Inc. and Alpha Tau Medical Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BRVE

Braveheart Bio, Inc.

$1.51B

$21.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

DRTS

Alpha Tau Medical Ltd

$1.34B

$14.89HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BRVE vs DRTS

growth of $100 · dividends reinvested · last 1y

BRVE +18.6% (+18.6%/yr)DRTS +13.8% (+13.8%/yr)BRVE compounded faster over this window

BRVE DRTS

Metrics side by side

Total return (annualized)

Metric	BRVE	DRTS
Total return (1Y)	N/A	243.44%
Total return CAGR (3Y)	N/A	59.26%
Total return CAGR (5Y)	N/A	8.59%

BRVE is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full BRVE analysis Full DRTS analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.